FDA Commissioner Scott Gottlieb Resigns
Wed / Mar 6th
FDA Commissioner Dr. Scott Gottlieb, who just announced plans to create federal CBD regulations, now says he will retire next month.
FDA
The US Food and Drug Administration (FDA) is currently working to understand how cannabis and isolated CBD products can be useful to American citizens. There are robust statistics and stories emerging as the FDA conducts cannabis research. Read more about these details in the following stories, and sign up for our newsletter to be the first to find out when news hits the wire.
FDA Commissioner to Host Public Meeting Covering CBD Regulation in April
Fri / Mar 1st
FDA Commissioner Dr. Scott Gotliebb is planning a meeting for public comment and testimony in April about creating a regulatory framework for CBD.
FDA Begins Planning CBD Regulatory Framework
Wed / Dec 26th
FDA Commissioner Scott Gottlieb says the agency has started creating a regulatory framework for CBD products, which were legalized via the 2018 Farm Bill.
FDA Chief: Federal Cannabis Action Is An ‘Inevitability’
Tue / Nov 20th
U.S. Food and Drugs Administration (FDA) Commissioner Scott Gottlieb said in a CNBC interview on Friday that a federal cannabis… Read More
First FDA-Approved CBD Medication Now Available In U.S.
Thu / Nov 1st
The first FDA-approved medication containing cannabidiol (CBD) sourced from cannabis plants is now available by prescription in all 50 U.S.… Read More
FDA Cannabis Rescheduling Comments Are Flooding In
Thu / Oct 18th
The FDA has received input from more than 2,000 individuals on the rescheduling of cannabis and other drugs just over… Read More
FDA Calls for Public Comment on Cannabis Rescheduling
Wed / Oct 10th
FDA officials have put out a call for public comment about the potential rescheduling of cannabis and several other substances.… Read More
FDA Says CBD Should Be Descheduled
Tue / Oct 2nd
An FDA evaluation of CBD drug Epidiolex that was recently made public shows that the FDA originally wanted to make… Read More
First FDA-Approved CBD Medication to Cost More than $32,000 Per Year
Thu / Aug 9th
GW Pharmaceuticals has revealed the expected consumer price for Epidiolex, the first cannabidiol-based medication to be approved by the FDA,… Read More
California to Block Hemp-Derived CBD From All Food Products
Tue / Jul 17th
The California Department of Public Health’s Food and Drug Branch (CDPH-FDB) updated an FAQ last week to address food products… Read More
FDA Approves CBD-Based Epidiolex
Mon / Jun 25th
The Food and Drug Administration approved GW Pharmaceuticals’ cannabidiol-based medication Epidiolex on Monday, according to the Washington Post. It is the… Read More
McConnell’s Bill Would Normalize the Hemp Industry
Fri / Apr 20th
Last week, Senate Majority Leader Mitch McConnell (R-KY) took to the chamber floor and laid out his case for the… Read More
Epidiolex Receives Initial Recommendation from FDA Committee
Fri / Apr 20th
Epidiolex, a CBD-based pharmaceutical medication created by GW Pharmaceuticals in the United Kingdom, has received a unanimous recommendation from an FDA… Read More
NORML Launches Website to Send FDA Public Comments Regarding Cannabis Rescheduling
Wed / Apr 11th
The Food and Drug Administration is asking for public comment on the international scheduling of cannabis following a request from… Read More
Massachusetts Alcohol Regulators Block CBD Beer Claiming FDA Rules Violation
Mon / Mar 26th
The Massachusetts Alcoholic Beverage Control Commission will not allow a local brewer to move forward with plans to roll out… Read More
MMJ Research Firm Secures Production License from Health Canada; One Step Closer to FDA Approval
Wed / Mar 14th
MMJ Bioscience is in the process of securing orphan drug status from the U.S. Food & Drug Administration for MMJ… Read More
FDA Requests Public Comments on Therapeutic Value of CBD
Mon / Sep 4th
The U.S. Food and Drug Administration (FDA) has put out a call for public comments regarding the therapeutic values and… Read More
CBD Seizure Drug Considered Effective Following FDA-Recognized Trials
Fri / May 26th
A new study published in the New England Journal of Medicine confirms what many patients, parents, advocates, and physicians already… Read More
Big Pharma Positioning for Federal Approval of Cannabis Drugs
Tue / Apr 4th OPINION
In my most recent publishing, I wrote that our hemp/CBD industry was being hijacked from us. “Us,” being those who… Read More
Hemp CBD Companies Should Worry About FDA, Not DEA, Intervention
Wed / Feb 8th
It’s been nearly two months since mainstream media outlets and several cannabis publications published headlines claiming that the Drug Enforcement… Read More
Trump Considering Cannabis Advocate for FDA Commissioner
Tue / Jan 24th
President Donald Trump has been announcing his nominations for the various positions in his administration since securing the election in… Read More
